Synbiotic approaches to human health and well-being

被引：30
|
作者：
Gurry, Thomas [1 ,2 ,3 ]
机构：
[1] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[2] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA
[3] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
来源：
MICROBIAL BIOTECHNOLOGY | 2017年 / 10卷 / 05期
关键词：
INFLAMMATORY-BOWEL-DISEASE; MILK OLIGOSACCHARIDES; SODIUM-BUTYRATE; IN-VITRO; FERMENTATION; MICROBIOTA; EPIDEMIC; OBESITY;
D O I：
10.1111/1751-7915.12789
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Synbiotics refer to combinations of probiotics and prebiotics that act synergistically to confer health benefits to the host. As a therapeutic strategy, they provide a gentle yet powerful method for modulating the composition and metabolic output of the human gut microbiota. In the context of achieving the UN Sustainable Development Goals, synbiotics have the potential to act as cost-effective prophylactic measures against a variety of human ailments, ranging from infant diarrhoea to metabolic and inflammatory diseases in adults, by maintaining commensal microbial communities and metabolic networks that are conducive to human health.
引用
收藏
页码：1070 / 1073
页数：4
相关论文
共 50 条
12345